/ Print /

Innovation in healthcare wearables continues to drive market growth.
New treatment indications are under investigation for the use of cannabinoid-based drugs.
Health plans of the future will focus on consumers: designing products, care and services to support improved health.
The proliferation of specialty drugs has prompted new techniques for keeping costs in tow.
Biomarker testing for harmful genetic mutations provides the opportunity to identify at-risk individuals who might benefit from risk modification strategies and/or enhanced disease screening.
Several changes and transitions will have a huge impact on health IT in 2017 and in future years.
Finding technology solutions to diagnose and manage chronic conditions is critical to the future of healthcare.
In order to survive as a managed care organization, it’s important to stay on top of policy changes and reimbursement trends.
Patients need cost information to make the best treatment decisions. But physicians are coming up short.
Find out about the latest treatment and drug pipeline developments
IN THE PIPELINE
First drug for rare skin cancer wins approval

FDA approved the first treatment for metastatic Merkel cell carcinoma (MCC), a rare, aggressive skin cancer.

New Parkinson's drug, 2 others approved
Gottlieb FDA nomination praised
Gottlieb Tapped for FDA Commissioner Spot
HOSPITAL & PROVIDER STRATEGY
Insulin treatment persistence varies ...

A study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United ...

Senior housing, healthcare ...
Prepare providers for telemedicine: ...
What providers need to do to improve ...
PHARMACY BEST PRACTICES
Insulin treatment persistence varies ...

A study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United ...

Five things to know about Trump’s ...
Opinion: More industry-stakeholders ...
Five pharmacy regulations health ...
HEALTH MANAGEMENT
Top drivers of diabetes care costs

How much does diabetes cost the healthcare system and what's driving cost increases? Find out.

Remote monitoring of diabetics: ...
Put drug development to work for ...
POLICY
Five things to know about Trump’s ...

On March 10, the White House announced that President Donald Trump selected Scott Gottlieb, MD, who has worked for FDA in ...

Opinion: More industry-stakeholders ...
Opinion: It’s time to rethink how we ...
Are high-value health plans the wave ...
Zika Virus
Brain volume, microcephaly on US ...

Research looks at the science showing associations between microcephaly and Zika virus. Plus: Can cervical pessaries help ...

Top ob/gyn stories of 2016
Looking back at 2016
Zika effects are more than ...
FOR YOUR BENEFIT

Latest Issue

MEETINGS / EVENTS

No events.

Event Resources

 

Stay current on the latest developments in your specialty with ModernMedicine's regularly updated collection of conference briefs and webinars.


Find us on Facebook

Follow Us On Twitter

Latest Tweets Follow